# Sylvia Kang

> Sylvia Kang is the CEO and co-founder of Mira (Miracare), the company behind the world's first FDA and CE-registered comprehensive at-home hormone monitoring platform. A former concert pianist who pivoted to biomedical engineering, she built Mira from her kitchen table into a 140-person company with 200,000+ users worldwide and over 50,000 women helped to conceive naturally. Named to Inc. Magazine's 2024 Female Founders 250 list and Femtech World's Leader of the Year, Kang holds an MS in Biomedical Engineering from Columbia and an MBA from Cornell, and used her own product to conceive after age 35.

- **Role:** CEO and Co-Founder at Mira (Miracare)
- **Organizations:** Mira, Miracare, Quanovate, Corning Incorporated
- **From:** China
- **Nationality:** Chinese-American
- **Education:** MS in Biomedical Engineering, Columbia University, MBA, Cornell University (Johnson Graduate School of Management)
- **Known for:** Named to Inc. Magazine's 2024 Female Founders 250 list, Femtech World 2024 Leader of the Year, Mira named one of Fast Company's World's Most Innovative Companies (2024)

## Career timeline

- **childhood** — Began piano training at age 4; competed in international piano competitions in France, China, and Hong Kong
- **age 18** — Studying at a music conservatory in China; began secretly self-studying physics using grandfather's textbooks at night
- **pre-2016** — Earned MS in Biomedical Engineering from Columbia University and MBA from Cornell University; immigrated to the US
- **pre-2016** — Held business and product director roles at Corning Incorporated (Fortune 500 life science company); managed a $100M global business operation
- **2016** — Co-founded Quanovate (later rebranded as Mira/Miracare) to develop at-home hormone tracking technology
- **2018** — Raised venture funding; integrated AI technology into Mira's core product, ahead of mainstream healthcare adoption
- **2018** — Led US operations and commercialization; built team to 30 employees
- **2023-2024** — Launched Ultra4, Mira's most advanced hormone-tracking device; Times Square campaign
- **2024** — Named to Inc. Magazine's Female Founders 250 list; named Femtech World Leader of the Year
- **2024** — Mira named one of Fast Company's World's Most Innovative Companies; Healthline Best Fertility Monitor award
- **2025** — Mira reaches 200,000+ users worldwide; 50,000+ women helped to conceive naturally

## Achievements

- Named to Inc. Magazine's 2024 Female Founders 250 list
- Femtech World 2024 Leader of the Year
- Mira named one of Fast Company's World's Most Innovative Companies (2024)
- Healthline 2024 Best Fertility Monitor award
- Built Mira into the first FDA and CE-registered comprehensive at-home women's hormone monitoring platform
- 99% clinical trial accuracy for Mira's hormone tracking
- Grew Mira to 200,000+ users and 140+ employees
- Helped 50,000+ women conceive naturally through Mira's technology
- Multiple international piano competition wins in France, China, and Hong Kong
- Managed $100M global business operations at Corning Incorporated

## Latest updates

- **2025-07** — Sylvia Kang appeared on the Fitt Insider podcast (episode #295) discussing leading change in women's health
- **2025-01** — Published article on Built In: 'How Can Employers Help Women in Menopause Thrive as Leaders?'
- **2024-08** — Published article on Built In: 'How AI Can Help More People Have Babies'
- **2024-04** — Named to Inc. Magazine's 2024 Female Founders 250 list
- **2024** — Mira named one of Fast Company's World's Most Innovative Companies and won Healthline Best Fertility Monitor
- **2024** — Named Femtech World Leader of the Year
- **2024** — Launched Ultra4, Mira's most advanced hormone tracking device, with Times Square campaign

## Links

- Website: https://miracare.com
- LinkedIn: https://www.linkedin.com/in/sylviakang/
- Twitter/X: https://twitter.com/mirafertility
- YouTube: https://www.youtube.com/watch?v=j9I-c6ilcSA
- Facebook: https://www.facebook.com/mirafertility/

---

Profile page: https://yespress.io/sylvia-kang
Published by YesPress — https://yespress.io
Last updated: 2026-05-11